Skip to content

Bath & Body Works BBWI Payments for Repurchase of Common Stock

Payments for Repurchase of Common Stock at other companies

Ashland logo
AshlandASH
$100M
Ulta Beauty, Inc. logo
Ulta Beauty, Inc.ULTA
Clorox logo
CloroxCLX
International Flavors & Fragrances logo
International Flavors & FragrancesIFF
Colgate-Palmolive logo
Colgate-PalmoliveCL
TJX Companies logo
TJX CompaniesTJX

Other financials

Income statement

See full
Revenue$1.4B-3.2%
Gross profit$587.0M-9.1%
Operating income$231.0M+10.5%
Net income$183.0M+74.3%
EPS (diluted)$0.90+83.7%

Balance sheet

See full
Cash & equivalents$820.0M+28.9%
Total debt$4.7B-5.4%
Total equity-$1.1B+21.9%
Total assets$5.0B+1.7%

Cash flow

See full
Operating cash flow$244.0M+29.8%
CapEx$49.0M+32.4%
Free cash flow$195.0M+29.1%

Valuation

See full
Market cap$4.18B-38.6%

Profitability

See full
Gross margin43.2%-1.4pp
Operating margin15.8%-1.7pp
Net margin10%-1.1pp
FCF margin10.6%+0.7pp

Returns & leverage

See full
Debt / equity262.3×
Current ratio1.4×0.0×

Where this comes from

Reported directly by Bath & Body Works in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Bath & Body Works’s 10-Q, filed May 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bath & Body Works's payments for repurchase of common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bath & Body Works's payments for repurchase of common stock?
Bath & Body Works (BBWI) reported payments for repurchase of common stock of $0 in Q1 2026.
How has Bath & Body Works's payments for repurchase of common stock changed year-over-year?
Bath & Body Works's payments for repurchase of common stock decreased by 100.0% year-over-year, from $136M to $0.
What is the long-term trend for Bath & Body Works's payments for repurchase of common stock?
Over 3 years (2021 to 2025), Bath & Body Works's payments for repurchase of common stock has grown at a -41.1% compound annual growth rate (CAGR), from $1.96B to $401M.